Attovia Therapeutics, Inc. carries a market capitalization of 634.10M, placing it among publicly traded companies globally.
| Market Cap | 634.10M |
| Enterprise Value | N/A |
Attovia Therapeutics, Inc.'s stock has declined approximately -36.57534% over the past 52 weeks. The 50-day moving average sits at 19.71, while the 200-day moving average is 19.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.57534% |
| 50-Day Moving Average | 19.71 |
| 200-Day Moving Average | 19.78 |
| Average Volume (20 Days) | N/A |
Attovia Therapeutics, Inc.'s most recent stock split took place on July 30, 2020 with a 5:1 split ratio.
| Last Split Date | 7/30/2020 |
| Split Ratio | 5:1 |